3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1002 participants.
Also called NCT04570345
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,002 participants
- Sponsor
- Registry
-
NCT04570345
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT04570345. Randomized; no masking; primary purpose treatment. Start 2021-01-01 (anticipated); primary completion 2021-08-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- 3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI
- Acronym
- BULK-STEMI
- Condition
- ST Elevation Myocardial Infarction
- Intervention (Drug)
- ticagrelor monotherapy
- Intervention (Drug)
- Aspirin with P2Y12 receptor inhibitor
- Lead sponsor
- Dong-A University
Record details
- Record id
cardio:ct-nct04570345- Content hash
f4f1fd7c89bf8fc6e4c9bb4a40be2ed2c4cee6e1dca8cfb40dbec47c030e33f6